Monday, July 20, 2020 4:28:48 PM
Hartford Great Health Announces New Cooperation Agreement With Shanghai Joint Publishing Company
ROSEMEAD, Calif., July 20, 2020 (GLOBE NEWSWIRE) -- Hartford Great Health Corp. (“Hartford” or the “Company”) (HFUS), a company focus on the development of the Sino-U.S. health industry, today announced Hartford International Education Technology (Shanghai) Co. Ltd. (“HFIE”), which is controlled by Hartford Great Health Management (Shanghai) Ltd. (“HFSH”), the subsidiary of the Company, has successfully signed a Cooperation Agreement (the “Agreement”) with Shanghai Joint Publishing Company (“SJP”) on July 6, 2020 who is a famous publisher of Shanghai Newspaper Group and also one of the famous publishers in China.
SJP has earned a well-known reputation in China and abroad and its targeted customers mainly focus on the educational intellectuals. The publisher brand and publications of SJP are highly influential within the Chinese academic community. Since 1986, SJP has published more than 3,000 titles of various subjects, of which more than 100 titles have won awards like the "China Book Award". SJP has also published books in a variety of genres and topics, such as humanities, law, philosophy and academic education. Furthermore, many of these publications, including subjects in humanities, social sciences, cultural classics, college textbooks, professional reference books and practical knowledge books, have been sold abroad. In recent years, SJP has added child development to its publication topics through the creation of a research group called the “Children’s Mental Health and Growth Research Association”.
"I am very glad to sign the Agreement with SJP which will highly expand our cooperation area in child education.” said Mr. Lianyue Song, Chairman and Chief Executive Officer of Hartford Great Health Corp. “The partnership between the Company and SJP aims to use the platform of SJP’s "Children's Mental Health and Growth Research Association" to engage in international communication and cooperation on the education and mental health project for children between 2 to 18 years old. The Company will also work with SJP to develop resources and publications related to children's mental health and growth. In addition to publish early education textbooks, the Company and SJP also plan to develop and establish children mental health evaluation standards which would be promoted to over 1,000 early education centers around the world. Moreover, we will organize annual seminar events in the topics of "International Early Education Expo" and "International Forum on Healthy Growth of Children" with these early education centers, and our ultimate goal of the cooperation is to increase the exposure of Company’s early education center franchise program through the social influences of SJP. We believe the cooperation of the Company and SJP will bring more economic interests of the Company’s early education business in the future.”
ABOUT HARTFORD GREAT HEALTH CORP.
Hartford Great Health Corp. is a development stage company that focus on the Sino-U.S. health industry through its subsidiaries in China. In 2020, the Company has found another opportunity to expand its market reach in the Chinese childhood education industry. The Company plans to formulate a proprietary early childhood education center management model beginning with the opening of several early childhood education centers in the greater Shanghai area with the goal of demonstrating the management model in action in order to attract interest from potential franchisees. To learn more, please visit www.hartfordgreathealth.com.
Recent HFUS News
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 03/06/2024 07:20:43 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 03/05/2024 10:14:49 PM
- Form SCHEDULE 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 03/05/2024 04:49:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/12/2023 09:02:30 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/30/2023 06:33:27 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM